eHealth financials
$0.7189−0.88%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.6M | $88.0M | $326.2M | $53.9M | $60.8M | $113.1M | $315.2M | $58.4M | $65.9M | $93.0M |
| Gross profit | $33.6M | $88.0M | $326.2M | $53.9M | $60.8M | $113.1M | $315.2M | $58.4M | $65.9M | $93.0M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$27.5M | -$2.9M | $126.3M | -$41.5M | -$23.0M | $4.8M | $112.6M | -$43.2M | -$28.0M | -$17.9M |
| Net income | -$37.5M | -$18.1M | $73.9M | -$44.6M | -$29.8M | -$10.0M | $85.7M | -$53.9M | -$39.0M | -$27.7M |
| Net margin | −111.8% | −20.6% | 22.7% | −82.8% | −49.0% | −8.8% | 27.2% | −92.4% | −59.2% | −29.8% |
| Diluted EPS | $-1.18 | $-0.58 | $2.39 | $-1.46 | $-0.98 | $-0.33 | $2.88 | $-1.83 | $-1.33 | $-0.96 |
| EBITDA | -$29.7M | $6.8M | $129.5M | -$37.9M | -$24.5M | $8.7M | $116.5M | -$39.3M | -$20.6M | -$7.2M |
| Operating cash flow | -$5.0M | $35.8M | -$35.9M | -$25.3M | -$41.2M | $77.1M | -$27.7M | -$29.3M | -$32.2M | $70.8M |
| Free cash flow | -$5.4M | $35.6M | -$36.1M | -$25.5M | -$42.8M | $76.8M | -$28.3M | -$30.3M | -$32.4M | $70.6M |
| Diluted shares | 31.8M | 31.1M | 30.9M | 30.6M | 30.4M | 30.0M | 29.7M | 29.5M | 29.2M | 28.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $69.7M | $75.1M | $73.7M | $63.1M | $65.9M | $121.1M |
| Short-term investments | $31.4M | $35.7M | $3.5M | $12.2M | $39.3M | $34.5M |
| Total debt | $114.6M | $113.8M | $113.0M | $69.4M | $69.1M | $68.8M |
| Total assets | $1.16B | $1.20B | $1.26B | $1.05B | $1.08B | $1.14B |
| Total liabilities | $210.9M | $231.5M | $288.8M | $162.9M | $165.9M | $207.6M |
| Shareholders' equity | $540.8M | $575.7M | $591.6M | $514.2M | $554.9M | $581.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology